{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:40:52Z","timestamp":1786621252765,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020217","name":"Sanjay Gandhi Postgraduate Institute of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific & Industrial Research","doi-asserted-by":"publisher","award":["CSIRAWARD\/SRFDIRECT2024\/14744"],"award-info":[{"award-number":["CSIRAWARD\/SRFDIRECT2024\/14744"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.nucmedbio.2026.109659","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:54:12Z","timestamp":1783468452000},"page":"109659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Automated radiosynthesis of [64Cu]Cu-FAPI-2286 for FAP-targeted PET imaging"],"prefix":"10.1016","volume":"158-159","author":[{"given":"Mohd","family":"Faheem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi Singh","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Gambhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.nucmedbio.2026.109659_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ph14101023","article-title":"New frontiers in cancer imaging and therapy based on radiolabeled fibroblast activation protein inhibitors: a rational review and current progress","volume":"14","author":"Imlimthan","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109659_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s44303-024-00053-z","article-title":"Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)","volume":"2","author":"Mori","year":"2024","journal-title":"npj Imaging"},{"issue":"8","key":"10.1016\/j.nucmedbio.2026.109659_bb0015","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1007\/s00259-022-05706-y","article-title":"Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond","volume":"49","author":"Li","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.nucmedbio.2026.109659_bb0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s13139-025-00936-y","article-title":"Exploring the diagnostic and theranostic role of FAPI PET in soft tissue sarcoma: a systematic review","volume":"59","author":"Abdulrahman","year":"2025","journal-title":"Nucl Med Mol Imaging"},{"issue":"12","key":"10.1016\/j.nucmedbio.2026.109659_bb0025","article-title":"FAPI PET\/CT imaging\u2014an updated review","volume":"13","author":"Chandekar","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"9","key":"10.1016\/j.nucmedbio.2026.109659_bb0030","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2967\/jnumed.123.265599","article-title":"Development of FAPI tetramers to improve tumor uptake and efficacy of FAPI radioligand therapy","volume":"64","author":"Pang","year":"2023","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.nucmedbio.2026.109659_bb0035","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.semnuclmed.2024.10.002","article-title":"Copper-64 based pet-radiopharmaceuticals: ways to clinical translational","volume":"54","author":"Yang","year":"2024","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109659_bb0040","series-title":"Fibroblast activation protein-targeted radioligands for cancer imaging and therapy","author":"Bendre","year":"2024"},{"key":"10.1016\/j.nucmedbio.2026.109659_bb0045","series-title":"Seminars in nuclear medicine","article-title":"Current status of FAP therapy in solid tumors","author":"Siegmund","year":"2025"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109659_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ph19010089","article-title":"Radiolabelled FAPI radiotracers in oncology: a comprehensive review of current diagnostic and emerging therapeutic applications","volume":"19","author":"Czuczejko","year":"2026","journal-title":"Pharmaceuticals (Basel)"},{"issue":"24","key":"10.1016\/j.nucmedbio.2026.109659_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17244019","article-title":"Therapeutic applications of fibroblast activation protein (FAP)-binding radiopharmaceuticals: review of opportunities and challenges","volume":"17","author":"Maes","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.nucmedbio.2026.109659_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ph17091141","article-title":"[68Ga] Ga-FAP-2286\u2014synthesis, quality control and comparison with [18F] FDG PET\/CT in a patient with suspected cholangiocellular carcinoma","volume":"17","author":"H\u00f6rmann","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109659_bb0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00259-024-06795-7","article-title":"Feasibility and therapeutic potential of [177Lu] Lu-FAPI-2286 in patients with advanced metastatic sarcoma","volume":"52","author":"Banihashemian","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2026.109659_bb0070","first-page":"10","article-title":"Efficacy of 177Lu-FAP-2286 and 225Ac-FAP-2286 in treating pancreatic adenocarcinoma with lymph node metastasis","author":"Tian","year":"2022","journal-title":"Clin Nucl Med"},{"issue":"10","key":"10.1016\/j.nucmedbio.2026.109659_bb0075","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2967\/jnumed.119.240143","article-title":"64Cu-DOTATATE PET\/CT and prediction of overall and progression-free survival in patients with neuroendocrine neoplasms","volume":"61","author":"Carlsen","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109659_bb0080","series-title":"Radiolabeling and formulation for scale up of 64Cu-DOTATATE. U.S. patent 12,102,696","author":"Pipes","year":"2024"},{"issue":"33","key":"10.1016\/j.nucmedbio.2026.109659_bb0085","first-page":"11500","article-title":"A practical guide on the synthesis of metal chelates for molecular imaging and therapy by means of click chemistry","volume":"22","author":"Notni","year":"2016","journal-title":"Chemistry (Weinheim an der Bergstrasse, Germany)"},{"issue":"41","key":"10.1016\/j.nucmedbio.2026.109659_bb0090","doi-asserted-by":"crossref","first-page":"19468","DOI":"10.1021\/acs.inorgchem.4c03571","article-title":"Radiochemistry and complex formation of the cyclen-derived chelator DOTI-Me with Mn2+, Cu2+, Zn2+, Ga3+, In3+, Tb3+, and Lu3+","volume":"63","author":"Hierlmeier","year":"2024","journal-title":"Inorg Chem"},{"key":"10.1016\/j.nucmedbio.2026.109659_bb0095","series-title":"7. Copper-64 radiopharmaceuticals: production, quality control and clinical applications","author":"Radioisotopes, I.A.E.A. and No, R.S","year":"2022"},{"issue":"4","key":"10.1016\/j.nucmedbio.2026.109659_bb0100","first-page":"379","article-title":"Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research","volume":"24","author":"Anderson","year":"2009","journal-title":"Cancer Biother Radiopharm"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109659_bb0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s41181-021-00149-6","article-title":"EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality","volume":"6","author":"Luurtsema","year":"2021","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109659_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41181-019-0086-z","article-title":"EANM guideline on the validation of analytical methods for radiopharmaceuticals","volume":"5","author":"Gillings","year":"2020","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.nucmedbio.2026.109659_bb0115","first-page":"1","article-title":"Synthesis, radiolabelling and preliminary evaluation of [68Ga] Ga-DOTA-linked cyanuric chloride\u2013glu-ureido scaffold for PSMA PET imaging","author":"Faheem","year":"2026","journal-title":"Mol Divers"},{"issue":"1","key":"10.1016\/j.nucmedbio.2026.109659_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-021-00856-w","article-title":"[68Ga] Ga-4HMSA a promising new PET tracer for imaging inflammation","volume":"11","author":"Kahn Ali","year":"2021","journal-title":"EJNMMI Res"},{"issue":"4","key":"10.1016\/j.nucmedbio.2026.109659_bb0125","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10534-014-9736-5","article-title":"The many \u201cfaces\u201d of copper in medicine and treatment","volume":"27","author":"Hordyjewska","year":"2014","journal-title":"Biometals"},{"key":"10.1016\/j.nucmedbio.2026.109659_bb0130","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2147\/DDDT.S170879","article-title":"Copper-64: a real theranostic agent","author":"Gutfilen","year":"2018","journal-title":"Drug Des Devel Ther"},{"issue":"11","key":"10.1016\/j.nucmedbio.2026.109659_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119154","article-title":"Recent advances in 64Cu\/67Cu-based radiopharmaceuticals","volume":"24","author":"Krasnovskaya","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nucmedbio.2026.109659_bb0140","series-title":"Mixed ligand complex of copper (II) containing ON donor ligands","author":"Sahoo","year":"2009"},{"issue":"8","key":"10.1016\/j.nucmedbio.2026.109659_bb0145","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1021\/ic00228a031","article-title":"Factors influencing Jahn-Teller distortions in six-coordinate copper (II) and low-spin nickel (II) complexes","volume":"25","author":"Deeth","year":"1986","journal-title":"Inorg Chem"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:26:20Z","timestamp":1786620380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805126000582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":29,"alternative-id":["S0969805126000582"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109659","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automated radiosynthesis of [64Cu]Cu-FAPI-2286 for FAP-targeted PET imaging","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109659"}}